MedPath

Assessment of Osseointegration Properties of Nano-Hydroxy Apatite Coated Titanium Implant

Not Applicable
Completed
Conditions
Implant Site Reaction
Registration Number
NCT05936775
Lead Sponsor
October University for Modern Sciences and Arts
Brief Summary

the purpose of this trial is to evaluate the osseointegration properties of nano-hydroxy apatite coated titanium implants in posterior maxilla. 30 patients will be included in this trial divided into two groups, control and intervention. Primary and secondary implant stability will be measured

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Patients with missing at least one maxillary posterior tooth
  2. Patients free from any systemic disease
  3. Patients who approve to be included in the trial and sign the informed consent
  4. Patients with no intra-bony defect.
  5. Adults aged 18 years old and above
Exclusion Criteria
  1. Patients who are allergic to titanium
  2. Heavy smoker patient
  3. Patients receiving chemotherapy or radiotherapy
  4. Patients who refused to be included in the trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Implant stability12 weeks post-operative

implant stability will be measured by radiofrequency analysis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

October University for Modern Sciences and Arts faulty of Dentistry

🇪🇬

Giza, Egypt

October University for Modern Sciences and Arts faulty of Dentistry
🇪🇬Giza, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.